EBS — Emergent BioSolutions Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Emergent BioSolutions, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K/A	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	168	621	576	643	112
Net Total Accounts Receivable
Net Total Receivables	275	272	275	159	191
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	686	1,196	1,272	1,210	680
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	567	675	828	837	399
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	2,327	2,883	2,959	3,166	1,823
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	216	385	374	1,229	651
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	1,239	1,436	1,340	1,779	1,174
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	1,089	1,447	1,619	1,388	649
Total Liabilities & Shareholders' Equity	2,327	2,883	2,959	3,166	1,823
Total Common Shares Outstanding
Total Preferred Shares Outstanding